FDA Extends Comment Period for Emerging Medical Device Signals Draft Guidance

January 28, 2016

On December 31, 2015, FDA released a draft guidance entitled “Public Notification of Emerging Postmarket Medical Device Signals (‘Emerging Signals’),” which stated its plans to take a more aggressive approach to reporting medical device safety warnings to the public.

When the draft guidance was initially published the FDA stated that anyone interested in providing feedback on the document would have until February 29, 2016 to do so. However, “due to the unanticipated high-level of interest from external stakeholders and the medical device community,” the Agency is extending that deadline. On Wednesday, January 27, FDA announced that interested persons will now have until March 29, 2016 to submit any comments, questions, or concerns on the draft guidance.

View our FDA News article for additional information on the contents of the draft guidance.

Are you in the process of developing a medical device? Do you have a device that needs FDA approval? We can help. Using our proprietary approach, we can help get your product through FDA cheaper, better, and faster. To learn more about our services and how we can help you, contact us today.



Quality & Compliance GMP

January 28, 2016

FDA Addresses Extrapolating Adult Data for Pediatric Use

In 2004, the FDA issued a guidance document, entitled “Premarket Assessment of Pediatric Medical Devices.”  The guidance stated that, when consistent with scientific principles, data can be...

Read More
General Regulatory Regulatory Sciences

January 28, 2016

Innovation vs. Safety: Another Definition for the “Chicken or the Egg”

We all know that the FDA’s mission is to promote and protect public health. However, in their effort to protect the public health, it seems that they may be inadvertently harming the industry that...

Read More
General Regulatory Regulatory Sciences

January 28, 2016

FDA Issues a Reminder on Excipients in Dietary Supplements

In the new guidance on substances that can be added to foods, including beverages and dietary supplements, the FDA reminds manufacturers that the excipients added to oral dosage forms of these...

Read More